Back to Search
Start Over
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer.
- Source :
- Clinical Breast Cancer; Oct2011, Vol. 11 Issue 5, p306-311, 6p, 1 Black and White Photograph, 2 Charts
- Publication Year :
- 2011
Details
- Language :
- English
- ISSN :
- 15268209
- Volume :
- 11
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Clinical Breast Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 66142349
- Full Text :
- https://doi.org/10.1016/j.clbc.2011.03.021